Back to Search Start Over

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Authors :
Howes OD
McCutcheon R
Agid O
de Bartolomeis A
van Beveren NJ
Birnbaum ML
Bloomfield MA
Bressan RA
Buchanan RW
Carpenter WT
Castle DJ
Citrome L
Daskalakis ZJ
Davidson M
Drake RJ
Dursun S
Ebdrup BH
Elkis H
Falkai P
Fleischacker WW
Gadelha A
Gaughran F
Glenthøj BY
Graff-Guerrero A
Hallak JE
Honer WG
Kennedy J
Kinon BJ
Lawrie SM
Lee J
Leweke FM
MacCabe JH
McNabb CB
Meltzer H
Möller HJ
Nakajima S
Pantelis C
Reis Marques T
Remington G
Rossell SL
Russell BR
Siu CO
Suzuki T
Sommer IE
Taylor D
Thomas N
Üçok A
Umbricht D
Walters JT
Kane J
Correll CU
Source :
The American journal of psychiatry [Am J Psychiatry] 2017 Mar 01; Vol. 174 (3), pp. 216-229. Date of Electronic Publication: 2016 Dec 06.
Publication Year :
2017

Abstract

Objective: Research and clinical translation in schizophrenia is limited by inconsistent definitions of treatment resistance and response. To address this issue, the authors evaluated current approaches and then developed consensus criteria and guidelines.<br />Method: A systematic review of randomized antipsychotic clinical trials in treatment-resistant schizophrenia was performed, and definitions of treatment resistance were extracted. Subsequently, consensus operationalized criteria were developed through 1) a multiphase, mixed methods approach, 2) identification of key criteria via an online survey, and 3) meetings to achieve consensus.<br />Results: Of 2,808 studies identified, 42 met inclusion criteria. Of these, 21 studies (50%) did not provide operationalized criteria. In the remaining studies, criteria varied considerably, particularly regarding symptom severity, prior treatment duration, and antipsychotic dosage thresholds; only two studies (5%) utilized the same criteria. The consensus group identified minimum and optimal criteria, employing the following principles: 1) current symptoms of a minimum duration and severity determined by a standardized rating scale; 2) moderate or worse functional impairment; 3) prior treatment consisting of at least two different antipsychotic trials, each for a minimum duration and dosage; 4) systematic monitoring of adherence and meeting of minimum adherence criteria; 5) ideally at least one prospective treatment trial; and 6) criteria that clearly separate responsive from treatment-resistant patients.<br />Conclusions: There is considerable variation in current approaches to defining treatment resistance in schizophrenia. The authors present consensus guidelines that operationalize criteria for determining and reporting treatment resistance, adequate treatment, and treatment response, providing a benchmark for research and clinical translation.

Details

Language :
English
ISSN :
1535-7228
Volume :
174
Issue :
3
Database :
MEDLINE
Journal :
The American journal of psychiatry
Publication Type :
Academic Journal
Accession number :
27919182
Full Text :
https://doi.org/10.1176/appi.ajp.2016.16050503